Acetylation: A new key to unlock tau's role in neurodegeneration

Casey Cook, Jeannette N. Stankowski, Yari Carlomagno, Caroline Stetler, Leonard Petrucelli

Research output: Contribution to journalReview article

57 Scopus citations

Abstract

The identification of tau protein as a major constituent of neurofibrillary tangles spurred considerable effort devoted to identifying and validating pathways through which therapeutics may alleviate tau burden in Alzheimer's disease and related tauopathies, including chronic traumatic encephalopathy associated with sport- and military-related injuries. Most tau-based therapeutic strategies have previously focused on modulating tau phosphorylation, given that tau species present within neurofibrillary tangles are hyperphosphorylated on a number of different residues. However, the recent discovery that tau is modified by acetylation necessitates additional research to provide greater mechanistic insight into the spectrum of physiological consequences of tau acetylation, which may hold promise as a novel therapeutic target. In this review, we discuss recent findings evaluating tau acetylation in the context of previously accepted notions regarding tau biology and pathophysiology. We also examine the evidence demonstrating the neuroprotective and beneficial consequences of inhibiting histone deacetylase (HDAC)6, a tau deacetylase, including its effect on microtubule stabilization. We also discuss the rationale for pharmacologically modulating HDAC6 in tau-based pathologies as a novel therapeutic strategy.

Original languageEnglish (US)
Article number29
JournalAlzheimer's Research and Therapy
Volume6
Issue number3
DOIs
StatePublished - May 29 2014

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Cognitive Neuroscience

Fingerprint Dive into the research topics of 'Acetylation: A new key to unlock tau's role in neurodegeneration'. Together they form a unique fingerprint.

  • Cite this